Portage Biotech Inc
NASDAQ:PRTG

Watchlist Manager
Portage Biotech Inc Logo
Portage Biotech Inc
NASDAQ:PRTG
Watchlist
Price: 4.7001 USD -0.84% Market Closed
Market Cap: 10.7m USD

Intrinsic Value

The intrinsic value of one PRTG stock under the Base Case scenario is 1.0412 USD. Compared to the current market price of 4.7001 USD, Portage Biotech Inc is Overvalued by 78%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

PRTG Intrinsic Value
1.0412 USD
Overvaluation 78%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation History
Portage Biotech Inc

What is Valuation History?
Ask AI Assistant
What other research platforms think about PRTG?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations
Why is PRTG valued this way?

Let our AI break down the key assumptions behind the intrinsic value calculation for Portage Biotech Inc.

Explain Valuation
Compare PRTG to

Fundamental Analysis

Company Overview
Loading...
Economic Moat
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about PRTG?
Bearish
Neutral
Bullish
Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Portage Biotech Inc

Current Assets 2.2m
Cash & Short-Term Investments 1.7m
Receivables 80k
Other Current Assets 475k
Current Liabilities 1.1m
Accounts Payable 427k
Accrued Liabilities 660k
Other Current Liabilities 13k
Non-Current Liabilities 1.2m
Other Non-Current Liabilities 1.2m
Efficiency

Free Cash Flow Analysis
Portage Biotech Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Portage Biotech Inc

Revenue
0 USD
Operating Expenses
-7.4m USD
Operating Income
-7.4m USD
Other Expenses
651k USD
Net Income
-6.8m USD
Fundamental Scores

PRTG Profitability Score
Profitability Due Diligence

Portage Biotech Inc's profitability score is 21/100. The higher the profitability score, the more profitable the company is.

Low 3Y Average Gross Margin
Low 3Y Average Net Margin
Low 3Y Average Operating Margin
Declining ROE
21/100
Profitability
Score

Portage Biotech Inc's profitability score is 21/100. The higher the profitability score, the more profitable the company is.

PRTG Solvency Score
Solvency Due Diligence

Portage Biotech Inc's solvency score is 37/100. The higher the solvency score, the more solvent the company is.

Low D/E
Short-Term Solvency
Long-Term Solvency
Low Altman Z-Score
37/100
Solvency
Score

Portage Biotech Inc's solvency score is 37/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

PRTG Price Targets Summary
Portage Biotech Inc

There are no price targets for PRTG.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
View Analyst Estimates
View Analyst Estimates

Dividends

Portage Biotech Inc
does not pay dividends
Shareholder Yield

Current shareholder yield for PRTG is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y
What is the Intrinsic Value of one PRTG stock?

The intrinsic value of one PRTG stock under the Base Case scenario is 1.0412 USD.

Is PRTG stock undervalued or overvalued?

Compared to the current market price of 4.7001 USD, Portage Biotech Inc is Overvalued by 78%.

Back to Top